Noguchi K, Noguchi Y, Hirose H, Nishikibe M, Ihara M, Ishikawa K, Yano M
New Drug Discovery Research Laboratories, Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., Japan.
Eur J Pharmacol. 1993 Mar 16;233(1):47-51. doi: 10.1016/0014-2999(93)90347-k.
In anesthetized and ventilated guinea-pigs, intravenous injections of endothelin (ET)-1 (0.5 nmol/kg), ET-3 (0.5 nmol/kg), and [Ala1,3,11,15]ET-1 (20 nmol/kg), an ETB-selective receptor agonist, induced bronchoconstrictor and transient vasoconstrictor responses. Only the ET-1-induced transient vasoconstriction was followed by a secondary sustained pressor response. The ETA-selective receptor antagonist, BQ-123 (1 mg/kg i.v.), attenuated only the sustained pressor response. These results indicate that the bronchoconstrictor and transient vasoconstrictor responses to endothelins in guinea-pigs are mediated by ETB receptors, whilst the sustained pressor response is mediated by ETA receptors. The thromboxane A2 receptor antagonist, L-670,596 (0.5 mg/kg, i.v.) and a high dose of BQ-123 (30 mg/kg i.v.) abolished the bronchoconstriction only without affecting the transient pressor response to endothelin isopeptides. These results suggest that the ETB-mediated bronchoconstriction depends on thromboxane A2 formation. The different sensitivity of these ETB-mediated transient responses to BQ-123 suggests the possible existence of distinct ETB receptor subtypes.
在麻醉并通气的豚鼠中,静脉注射内皮素(ET)-1(0.5 nmol/kg)、ET-3(0.5 nmol/kg)以及ETB选择性受体激动剂[Ala1,3,11,15]ET-1(20 nmol/kg),可诱导支气管收缩和短暂的血管收缩反应。只有ET-1诱导的短暂血管收缩之后会出现继发性持续性升压反应。ETA选择性受体拮抗剂BQ-123(1 mg/kg静脉注射)仅减弱了持续性升压反应。这些结果表明,豚鼠对内皮素的支气管收缩和短暂血管收缩反应由ETB受体介导,而持续性升压反应由ETA受体介导。血栓素A2受体拮抗剂L-670,596(0.5 mg/kg,静脉注射)和高剂量的BQ-123(30 mg/kg静脉注射)仅消除了支气管收缩,而不影响对内皮素异肽的短暂升压反应。这些结果表明,ETB介导的支气管收缩依赖于血栓素A2的形成。这些ETB介导的短暂反应对BQ-123的不同敏感性表明可能存在不同的ETB受体亚型。